Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03786692
Brief Title: Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

First Submitted : December 21, 2018
First Submitted that Met QC Criteria : December 24, 2018
First Posted : December 26, 2018

Last Update Submitted that Met QC Criteria : October 7, 2020
Last Update Posted : October 8, 2020